Page last updated: 2024-10-18

imidazole and Hepatocellular Carcinoma

imidazole has been researched along with Hepatocellular Carcinoma in 1 studies

imidazole: RN given refers to parent cpd
1H-imidazole : An imidazole tautomer which has the migrating hydrogen at position 1.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Aruchamy, B1
Drago, C1
Russo, V1
Pitari, GM1
Ramani, P1
Aneesh, TP1
Benny, S1
Vishnu, VR1

Other Studies

1 other study available for imidazole and Hepatocellular Carcinoma

ArticleYear
Imidazole-pyridine hybrids as potent anti-cancer agents.
    European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2023, Jan-01, Volume: 180

    Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Glycogen Synthase Kinase 3 beta; Humans; Liver Neo

2023